NAACCR Item #3857: High Risk Cytogenetics
|Item #||Length||Source of Standard||Year Implemented||Version Implemented||Year Retired||Version Retired|
NAACCR XML: Tumor.highRiskCytogenetics
High Risk Cytogenetics is defined as one or more of t(4;14), t(14;16), or del 17p identified from FISH test results and is part of the staging criteria for plasma cell myeloma.
High Risk Cytogenetics is a prognostic factor required in AJCC 8th edition, Chapter 82 Plasma Cell Myeloma and Plasma Cell Disorders, for staging of plasma cell myeloma.
|0||High-risk cytogenetics not identified/not present|
|1||High-risk cytogenetics present|
|5||Schema Discriminator 1: Plasma Cell Myeloma Terminology coded to 1 or 9|
|7||Test ordered, results not in chart|
|9||Not documented in medical record|
High Risk Cytogenetics not assessed or unknown if assessed
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.